AI-based Drug Re-innovation
BioXcel Therapeutics, Inc. is a
biopharmaceutical company developing transformative medicines in neuroscience utilizing artificial intelligence.
Innovative Medicine
Backed by the
Power of
BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques.
Innovative Medicine
Backed by the Power of
BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques.
Our Approach to Drug Development
- Optimizes R&D economics
- Shortens development timelines
- Increases probability of success
May 28, 2024
BioXcel Therapeutics to Present at Jefferies Global Healthcare ConferenceVIEW RELEASE
May 21, 2024
BioXcel Therapeutics Announces Oral and Poster Presentations at the 2024 American Society of Clinical Psychopharmacology (ASCP) Annual MeetingVIEW RELEASE
May 09, 2024
BioXcel Therapeutics Reports First Quarter 2024 Financial ResultsVIEW RELEASE
Stock Information
BioXcel Therapeutics, Inc.
May 31, 2024 04:00 PM
MARKET/SYMBOL
Nasdaq:
BTAI
PRICE
1.81
CHANGE
0.03 (1.69%)
